Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 85
Selected: 0
NCT IDTitle
NCT06494397Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions
NCT03619902A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis
NCT03373201Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
NCT00291187VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia
NCT04697056A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis
NCT06804603A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
NCT06836557Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
NCT04622345Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies
NCT04969211Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers
NCT01526746Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function
NCT01429116Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
NCT04140695Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)
NCT03568331Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)
NCT01271387Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment
NCT04326426ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection
NCT07362017Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
NCT00254202Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
NCT04849559Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers
NCT07446439A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
NCT03633396A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis
NCT03838926Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
NCT05344365A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis
NCT06961968Randomized Withdrawal Study in Patients With Schizophrenia
NCT03154697Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances
NCT02621385Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects
NCT01402076A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects
NCT04800237Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety
NCT01540500Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine
NCT02413918Iloperidone in Mixed States of Bipolar Disorder
NCT04353401WGS Analysis of COVID-19 Positive Patients
NCT02180451Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)
NCT04697069A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash
NCT05366855Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPP
NCT01477619Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects
NCT02560103An Observational Study to Investigate the Effects of Rapid Transmeridian Travel
NCT01637636Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.
NCT06830044Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
NCT00467441VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
NCT01291511Relapse Prevention Study in Patients With Schizophrenia
NCT04856917A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris
NCT04028492Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
NCT02004041Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis
NCT07065773Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
NCT05648591Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
NCT01163032Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
NCT01578057Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol
NCT01495169Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
NCT01195558Patient Registry of Blind Subjects With Sleep-related Problems
NCT02130999Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
NCT06803290Food Effect Study of VHX-896 in Healthy Volunteers